Individualized Medicine
October 22, 2025
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
February 28, 2020
February 11, 2020
January 21, 2020
January 6, 2020
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community